Validity of INR’s pioneering work re-confirmed

November 3, 2011

A newly published randomized study from Chiba University in Japan provides robust scientific support for the   pioneering work of the Institute of Neurological Recovery utilizing novel methods of delivery and indications for etanercept. The new study, published ahead-of-print in the leading journal Spine demonstrated the superiority of epidural administration of etanercept over an epidural steroid injection for treatment of sciatica associated with spinal stenosis. This method of treatment was invented at the INR (U.S. patent 6,419,944, issued to Edward Tobinick M.D., filed April 5, 2001). When the INR first published our work with etanercept for sciatica in 2003 and 2004 there were many who were [incorrectly] skeptical. This new study joins a favorable randomized, placebo-controlled study conducted by the U.S. Army in conjunction with Johns Hopkins researchers published in 2009 after their [uncredited] consultation with us several years before. Pleased that the truth has again been confirmed.